Raltegravir With Optimized Background Therapy for Resistant HIV-1 Infection
New England Journal of Medicine - United States
doi 10.1056/nejmoa0708975
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 24, 2008
Authors
Publisher
Massachusetts Medical Society